Payers are here. Are pharmacists ready?

Are payers ready to reward quality and outcomes?

Global Health Governance Challenges 2016 – Are We Ready?

The year 2016 could turn out to be a turning point for global health, new political realities and global insecurities will test governance and financing mechanisms in relation to both people and planet. But most importantly political factors such as the global power shift and “the rise of the rest” will define the future of global health. A new mix of health inequity and security challenges has...

Extending the Role of Pharmacists in Patient Care: Are Pharmacists in Developing Nations Ready to Change?

Patient care in a community is becoming critical due to change in the impact of diseases on health. The provision of pharmaceutical care in a community will bring in positive changes in health care delivery. However, the pharmacist in developing countries has remained obscure in direct healthcare of the patient. The main aim of this article is to reinforce the concept that there is a need to st...

Are payers treating orphan drugs differently?

BACKGROUND Some orphan drugs can cost hundreds of thousands of dollars annually per patient. As a result, payer sensitivity to the cost of orphan drugs is rising, particularly in light of increased numbers of new launches in recent years. In this article, we examine payer coverage in the United States, England and Wales, and the Netherlands of outpatient orphan drugs approved between 1983 and 2...

Are acute stroke-ready hospitals ready?

I n 2005, an American Stroke Association Task Force report described the rationale and components of an integrated stroke system of care extending from primordial prevention through primary prevention, acute management, secondary prevention, and poststroke rehabilitation and recovery. 1 The principle that optimal patient outcomes depend on the consistent implementation of care processes that ar...